Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Bibliographic Details
Main Authors: Robinson, PC, Richards, D, Tanner, HL, Feldmann, M
Format: Journal article
Language:English
Published: Elsevier 2020

Similar Items